Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Surgical margins in breast conserving surgery for ductal carcinoma in situ of the breast and clinical outcomes: a national audit with long term follow-up.
Journal: EClinicalMedicine
Published: March 17, 2025
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Journal: EBioMedicine
Published: February 18, 2022
Protection from covid-19 at work: health and safety law is fit for purpose.
Journal: BMJ (Clinical research ed.)
Published: December 15, 2021
Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2021
Transforming the 2-week wait (2WW) pathway: management of breast pain in primary care.
Journal: BMJ open quality
Published: August 16, 2021
COVID-19 vaccine efficacy data: solid enough to delay second dose?
Journal: Lancet (London, England)
Published: February 25, 2021
Was enough, and is enough, being done to protect the primary care workforce from COVID-19?
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: February 23, 2021
Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
Journal: Lancet (London, England)
Published: February 16, 2021
Reaffirming health and safety precautionary principles for COVID-19 in the UK.
Journal: Lancet (London, England)
Published: November 22, 2020
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 23, 2020
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.
Journal: NPJ breast cancer
Published: May 29, 2020
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 09, 2019
Last Updated: 09/26/2026